CALGB-90601
|
CALGB
|
A Randomized Double-Blinded Phase III Study Comparing Gemcitabine; Cisplatin; and Bevacizumab to Gemcitabine; Cisplatin; and Placebo in Patients with Advanced Transitional Cell Carcinoma
|
Adult CIRB - Late Phase Emphasis
|
Completed
|
|
CALGB-90802
|
CALGB
|
Randomized Phase III Trial Comparing Everolimus Versus Everolimus Plus Bevacizumab for Advanced Renal Cell Carcinoma Progressing After Treatment with Tyrosine Kinase Inhibitors
|
Adult CIRB - Late Phase Emphasis
|
Completed
|
|
CCTG CE.7
|
NCIC CTG
|
A Phase III Trial of Stereotactic Radiosurgery Compared with Hippocampal-Avoidant Whole Brain Radiotherapy (HA-WBRT) Plus Memantine for 5-15 Brain Metastases
|
Adult CIRB - Late Phase Emphasis
|
Available to Open
|
|
CCTG MA.39
|
NCIC CTG
|
Tailor RT: A Randomized Trial of Regional Radiotherapy in Biomarker Low Risk Node Positive Breast Cancer
|
Adult CIRB - Late Phase Emphasis
|
Available to Open
|
|
CCTG-BR38
|
CCTG
|
Consolidative Use of Radiotherapy to Block (CURB2) Oligoprogression in Patients with Metastatic Non-Small-Cell Lung Cancer - A Randomized Phase 3 Trial
|
Adult CIRB - Late Phase Emphasis
|
Available to Open
|
|
CCTG-CO32
|
CCTG
|
The NEO-RT Trial: A Phase 3 Randomized Trial of Neoadjuvant Chemotherapy, Excision and Observation versus ChemoRadioTherapy for Early Rectal Cancer
|
Adult CIRB - Late Phase Emphasis
|
Available to Open
|
|
CCTG-HN11
|
NCIC CTG
|
SPECT-CT Guided Elective Contralateral Neck Treatment (Select) for Patients with Lateralized Oropharyngeal Cancer: A Phase III Randomized Controlled Trial
|
Adult CIRB - Late Phase Emphasis
|
Available to Open
|
|
CCTG-NE1
|
CCTG
|
NET RETREAT: A Phase II Study of 177 Lutetium-DOTATATE Retreatment vs. Everolimus in Metastatic/Unresectable Midgut NET
|
Adult CIRB - Late Phase Emphasis
|
Available to Open
|
|
CCTG-PR24
|
CCTG
|
Androgen Suppression Combined with Elective Nodal Irradiation and Dose Escalated Prostate Treatment: A Non-Inferiority, Phase III Randomized Controlled Trial of Stereotactic Body Radiation Therapy versus Brachytherapy Boost in Patients with Unfavourable Risk Localized Prostate Cancer (ASCENDE SBRT)
|
Adult CIRB - Late Phase Emphasis
|
Available to Open
|
|
CCTG-PR26
|
CCTG
|
A Randomized Phase III Clinical Trial for the Addition of Docetaxel to Androgen Receptor Pathway Inhibitors in Patients with Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response (TRIPLE-SWITCH)
|
Adult CIRB - Late Phase Emphasis
|
Available to Open
|
|